MARC record from Internet Archive

LEADER: 04063cam 2200817Ii 4500
001 ocn466384005
003 OCoLC
005 20221014023545.0
008 091117s2009 ne a ob 001 0 eng d
006 m o d
007 cr |||||||||||
040 $aMBB$beng$erda$epn$cMBB$dOCLCQ$dOPELS$dOCLCQ$dOPELS$dOCLCF$dOCLCQ$dYDX$dITD$dOCLCA$dMEU$dOCLCO
019 $a978676250
020 $a9780123750105$q(electronic bk.)
020 $a0123750105$q(electronic bk.)
020 $a9780080962467
020 $a0080962467
035 $a(OCoLC)466384005$z(OCoLC)978676250
050 4 $aQH431.A1$bA3 v.67 eb
070 0 $aRB155.8$b.T57 2009
082 04 $a615.8/95$223
245 00 $aTissue-Specific Vascular Endothelial Signals and Vector Targeting.$nPart A /$cedited by Renata Pasqualini and Wadih Arap.
264 1 $aAmsterdam :$bElsevier,$c2009.
300 $a1 online resource (vii, 125 pages :$billustrations).
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aAdvances in genetics ;$vv. 67
546 $aText in English.
504 $aIncludes bibliographical references and index.
588 0 $aPrint version record.
520 $aThe field of genetics is rapidly evolving and new medical breakthroughs are occuring as a result of advances in knowledge of genetics. This series continually publishes imporatnt reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines. * Provides contrasting roles of VEGF, giving researchers a better understanding of the underlying mechanisms of VEGF *Includes chapters that review research employing a variety of organisms, allowing researchers to compare and contrast *Focuses on material that translates basic research to real-life treatment applications, showing primary researchers how the basic science is being used in the clinical setting.
505 00 $tInhibition of vascular endothelial growth factor receptor signaling in angiogenic tumor vasculature /$rMarina V. Backer, Carl V. Hamby, and Joseph M. Backer --$tAdeno-associated viral vectors and their redirection to cell-type specific receptors /$rStefan Michelfelder and Martin Trepel --$tTissue-specific targeting based on markers expressed outside endothelial cells /$rMikhail G. Kolonin --$tLigand-directed cancer gene therapy to angiogenic vasculature / Wouter H.P. Driessen [and others].
650 0 $aGene therapy.
650 0 $aAdenoviruses.
650 0 $aTissue-specific antigens.
650 0 $aVascular endothelium.
650 0 $aGene targeting.
650 0 $aGenetic vectors.
650 0 $aVascular endothelial growth factors.
650 2 $aGene Targeting
650 2 $aGenetic Therapy
650 2 $aGenetic Vectors
650 2 $aVascular Endothelial Growth Factors
650 2 $aAdenoviridae
650 2 $aOrgan Specificity
650 2 $aEndothelium, Vascular
650 6 $aThérapie génique.
650 6 $aAdénovirus.
650 6 $aAntigènes spécifiques de tissus.
650 6 $aEndothélium vasculaire.
650 6 $aGènes$xCiblage.
650 6 $aVecteurs de clonage.
650 6 $aFacteurs de croissance des cellules endothéliales vasculaires.
650 7 $aAdenoviruses.$2fast$0(OCoLC)fst00796586
650 7 $aGene therapy.$2fast$0(OCoLC)fst00939638
650 7 $aTissue-specific antigens.$2fast$0(OCoLC)fst01151497
650 7 $aVascular endothelium.$2fast$0(OCoLC)fst01164498
655 4 $aElectronic books.
700 1 $aPasqualini, Renata,$eeditor.
700 1 $aArap, Wadih,$eeditor.
776 08 $cOriginal$z9780123750105$z0123750105$w(OCoLC)424556231
830 0 $aAdvances in genetics ;$vv. 67.
856 40 $3ScienceDirect$uhttp://www.sciencedirect.com/science/book/9780123750105
938 $aYBP Library Services$bYANK$n6791885
029 1 $aAU@$b000044999977
029 1 $aCHBIS$b010354973
029 1 $aCHVBK$b329761366
029 1 $aDEBSZ$b405325894
994 $aZ0$bGTX
948 $hNO HOLDINGS IN GTX - 170 OTHER HOLDINGS